SRZN
Surrozen Inc · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website urrozen.com
- Employees(FY) 74
- ISIN US86889P2083
Performance
-6.65%
1W
+2.47%
1M
-19.58%
3M
+55.28%
6M
+1.59%
YTD
+15.76%
1Y
Profile
Surrozen, Inc., a clinical stage biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. The company is developing antibody-based therapeutics with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its products in pipeline include SZN-043, a hepatocyte-specific R-spondin mimetic bispecific fusion protein, which is in Phase 1b clinical trial for the treatment of severe liver diseases, including alcoholic hepatitis and asialoglycoprotein receptor 1; and SZN-1326, a bi-specific antibody, which is in Phase 1b clinical trial for the treatment of moderate to severe inflammatory bowel disease, Frizzled, and LRP receptors. The company also develops SZN-413, a Fzd4 targeted bi-specific antibody, which is in preclinical stage for the treatment of retinal vascular associated diseases. Surrozen, Inc. has collaboration and license agreement with Boehringer Ingelheim International GmbH to research, develop, and commercialize Fzd4 bi-specific antibodies. Surrozen, Inc. was founded in 2015 and is based in South San Francisco, California.
Technical Analysis of SRZN 2024-05-10
Overview:
In analyzing the technical indicators for SRZN over the last 5 days, we will delve into the trends, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming days.
Trend Analysis:...
Recent News & Updates
- 2024-05-08 20:30
- 2024-05-08 11:55
SRZN Stock Earnings: Surrozen Beats EPS for Q1 2024(Investorplace)
- 2024-05-08 04:05
- 2024-04-14 00:52
10 Buy-Rated Stocks with Latest Insider Purchases(Insidermonkey)
- 2024-04-02 20:40
- 2024-03-31 20:30
- 2024-03-31 20:30
- 2024-01-17 20:58
- 2024-01-17 19:30
Surrozen Provides Corporate Update on Clinical Programs(Globenewswire)
- 2023-12-13 16:52
SRZN Stock Earnings: Surrozen Misses EPS for Q1 2023(Investorplace)
- 2023-12-13 16:51
SRZN Stock Earnings: Surrozen Beats EPS for Q2 2023(Investorplace)
- 2023-11-08 03:05
Surrozen Provides Third Quarter 2023 Financial Results(Globenewswire)
- 2023-08-09 04:05
Surrozen Provides Second Quarter 2023 Financial Results(Yahoo Finance)
- 2023-06-04 20:30
- 2023-05-10 04:05
- 2023-04-04 20:30
- 2023-03-27 16:59
- 2023-03-22 04:01
- 2023-03-20 04:30
- 2023-01-04 03:41
- 2022-11-14 03:30
- 2022-10-09 20:00
- 2022-10-05 20:00
- 2022-09-25 20:00
- 2022-08-10 20:00
Surrozen Reports Second Quarter 2022 Financial Results(Yahoo Finance)
- 2022-06-26 22:34
- 2022-06-12 20:00
- 2022-05-23 20:00
- 2022-05-17 20:00
- 2022-05-15 20:00
Page 1 of 2
previousnext